Appelt J, Baranowsky A, Jahn D, Yorgan T, Köhli P, Otto E, Farahani S K, Graef F, Fuchs M, Herrera A, Amling M, Schinke T, Frosch K-H, Duda GN, Tsitsilonis S, Keller J
Impaired fracture healing represents an ongoing clinical challenge, as treatment options remain limited. Calcitonin gene-related peptide (CGRP), a neuropeptide targeted by emerging anti-migraine drugs, is also expressed in sensory nerve fibres innervating bone tissue.
